As it has for the past eight years, Take Control of Your Diabetes (TCOYD) is holding nationwide conferences on type 1 and type 2 diabetes . Notable speakers in the...

Kelly reveals how you can help change the truly unacceptable care people with diabetes are receiving in prison.

In late November, Vivus launched its Get Started! Program , which gives potential users of its weight management medication Qsymia a chance to try the drug free for two...

Weight expert Dr. David Cummings discusses why bariatric surgery goes far beyond weight loss for type 2 diabetes.

The development of a pen device for the once weekly GLP-1 agonist Bydureon (exenatide once-weekly) has hit a snag. Amylin (the drug’s manufacturer) had previously said...

In late June, diaTribe sent our team to Chicago to attend the 67th Annual Scientific Sessions of the American Diabetes Association.

Many people with diabetes fear eye diseases leading to blindness. In diabetic macular edema (DME), the leading cause of blindness among working-age Americans (over 560,...

Kerri Morrone Sparling reveals how the Internet has built an all new kind of diabetes community.

On January 11, an advisory panel recommended that the FDA approve Johnson & Johnson’s SGLT-2 inhibitor, Invokana (canagliflozin). The panel voted 10-5 in favor of...

Michelle Obama at the Partnership for a Healthier America’s Summit.

Kelly reflects on some changes here at diaTribe and in the world of diabetes and obesity.

A new study from the University of North Carolina and the Chinese Center for Disease Control (CCDC) has found that diabetes is four times more common among Chinese...

Kerri Sparling digs deep and tells us more about why social networking really does matter.

A study in the Journal of the American Medical Association ( JAMA ) found that patients with type 2 diabetes who had been taking the GLP-1 agonists Bydureon (exenatide...

When it comes to patient advocacy, Kerri Morrone Sparling explains why even the little things can have a big impact.

On December 14, the FDA granted 510(k) clearance for Insulet’s next-generation, much smaller OmniPod insulin patch pump, concluding a lengthy 19-month US regulatory...

What really causes weight gain? A fascinating review in the New England Journal of Medicine details myths and facts about obesity.

In June 2012, Medtronic held an Investor Conference to describe its upcoming products and expectations for the next five years. One of the biggest news items for...

Dr. Diana Guthrie, winner of the AADE Living Legend Award, on controlled breathing and supplements for people with diabetes…

By Hannah Deming Lately, the use of basal insulins (such as Lantus and Levemir) in combination with GLP-1 agonists (such as Byetta , Victoza , and Bydureon ) has been...